Encompass Health Corporation (NYSE:EHC) Shares Purchased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. increased its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 6.8% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 296,861 shares of the company's stock after purchasing an additional 18,885 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.29% of Encompass Health worth $30,066,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in EHC. US Bancorp DE raised its stake in Encompass Health by 9.6% in the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock valued at $127,000 after purchasing an additional 121 shares during the last quarter. Signaturefd LLC raised its stake in Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after purchasing an additional 125 shares during the last quarter. Arlington Trust Co LLC raised its stake in Encompass Health by 22.9% in the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after purchasing an additional 125 shares during the last quarter. Merit Financial Group LLC raised its stake in Encompass Health by 4.1% in the 1st quarter. Merit Financial Group LLC now owns 4,220 shares of the company's stock valued at $427,000 after purchasing an additional 166 shares during the last quarter. Finally, Sequoia Financial Advisors LLC raised its stake in Encompass Health by 6.7% in the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock valued at $276,000 after purchasing an additional 172 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, EVP John Patrick Darby sold 10,000 shares of the business's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the transaction, the executive vice president directly owned 79,710 shares of the company's stock, valued at $9,149,910.90. The trade was a 11.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider directly owned 11,958 shares of the company's stock, valued at $1,394,422.38. The trade was a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 132,663 shares of company stock worth $16,034,082 over the last 90 days. Corporate insiders own 2.00% of the company's stock.

Analysts Set New Price Targets

Several research firms recently commented on EHC. Barclays increased their price objective on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. UBS Group lifted their price objective on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Wall Street Zen downgraded Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective for the company in a research report on Thursday, June 5th. Finally, Truist Financial reiterated a "buy" rating and issued a $135.00 target price (up from $116.00) on shares of Encompass Health in a report on Monday, April 28th. Seven equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $131.50.

Encompass Health Trading Down 0.3%

Shares of Encompass Health stock traded down $0.35 during trading hours on Friday, hitting $110.01. The company's stock had a trading volume of 266,439 shares, compared to its average volume of 730,093. Encompass Health Corporation has a twelve month low of $82.74 and a twelve month high of $123.13. The firm has a fifty day moving average of $119.18 and a 200-day moving average of $106.70. The stock has a market cap of $11.09 billion, a price-to-earnings ratio of 22.70, a P/E/G ratio of 2.23 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.06 and a current ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the prior year, the company posted $1.12 EPS. The company's quarterly revenue was up 10.6% on a year-over-year basis. Research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st were paid a $0.17 dividend. The ex-dividend date was Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.62%. Encompass Health's dividend payout ratio (DPR) is 14.05%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.